Each year, oncology professionals around the globe convene for The European Society for Medical Oncology Congress. MD Anderson's experts present the latest advances in cancer care and lead the discussion of its application in the clinic to benefit patients. From promising discoveries in Phase I clinical trials to expanding and improving immunotherapies, our research is saving lives and preserving patients' quality of life.
Below is a snapshot of the work our experts are presenting at The European Society for Medical Oncology Congress 2022 as well as more on our pacesetting patient care.
with refractory metastatic colorectal cancer experience survival
benefits with fruquintinib
Findings from the global FRESCO-2 clinical trial show fruquintinib significantly improved overall survival and progression-free survival in patients with refractory metastatic colorectal cancer
Immunotherapy Improves Outlook in High-Risk Melanoma
Starting pembrolizumab before surgery instead of waiting until after surgery significantly improves the outlook for patients with stage III-IV melanoma
MD Anderson Research Highlights: ESMO 2022 Special Edition
MD Anderson experts will present several oral presentations at the European Society for Medical Oncology (ESMO) Congress 2022. Highlights include promising early data from a novel T cell therapy for solid tumors, targeted therapy progress in rare and advanced cancers and biomarkers of immunotherapy response.
James P. Allison Institute
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
Moon Shots Program
MD Anderson's Moon Shots® Program aims to rapidly and dramatically improve the disease's survival rates and reduce suffering through early detection, research and new treatments.Learn more about the Moon Shots Program